Microbot Medical MBOT Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -32.4%+253pp | -285%-103pp | -182.2%-60.7pp | -121.5%-63.1pp | |
| Return on invested capital | -39.3%+794pp | -833%-573pp | -260.3%+126pp | -386.2%-63.6pp | |
| Liquidity | |||||
| Current ratio | 23.3×+21.0× | 2.4×+0.3× | 2.1×-2.2× | 4.3×-3.7× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | |||||
| Book value per share | $1.69+651% | $0.23-48.9% | $0.44-56.0% | $1.00-50.4% | |
| Valuation | |||||
| Market capitalization | $128.28M+36.1% | $18.96M-1.2% | $19.2M-19.2% | $23.75M-55.4% | |
| Price / book | 1.7×-1.4× | 5.4×+1.1× | 4.3×+1.0× | 3.3×-0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Microbot Medical's ratios come from?
- Every ratio is computed from Microbot Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
